Company Filing History:
Years Active: 2015-2019
Title: Innovations of Chang Hee Min
Introduction
Chang Hee Min is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on biguanide derivatives. With a total of nine patents to his name, his research focuses on developing compounds that can effectively treat various health conditions.
Latest Patents
Chang Hee Min's latest patents include a biguanide derivative and a preparation method thereof, along with a pharmaceutical composition containing the biguanide derivative as an active ingredient. This compound, represented by Formula 1, demonstrates excellent effects on the activation of AMPKα and the inhibition of cancer cell proliferation at low doses compared to conventional drugs. It holds potential for treating diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, and cancer. Another notable patent involves N1-cyclic amine-N5-substituted biguanide derivatives, which also show promise in inhibiting cancer cell proliferation, metastasis, and recurrence through AMPK activation, even when administered in small doses.
Career Highlights
Throughout his career, Chang Hee Min has worked with notable companies such as Immunomet Therapeutics Inc. and Hanall Biopharma Co., Ltd. His work in these organizations has contributed to advancements in pharmaceutical research and development.
Collaborations
Chang Hee Min has collaborated with talented individuals in his field, including Yong Eun Kim and Ji Sun Lee. Their combined expertise has furthered the impact of his innovative research.
Conclusion
Chang Hee Min is a distinguished inventor whose work on biguanide derivatives has the potential to revolutionize treatments for various diseases. His contributions to pharmaceutical innovation continue to pave the way for future advancements in healthcare.